Default policies and parents’ consent for school-located HPV vaccination

Reiter, Paul L.; McRee, Annie-Laurie; Pepper, Jessica K.; Brewer, Noel T.

doi:10.1007/s10865-012-9397-1

Cited by 41 publications

(41 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9,11,41,63,74 Other studies suggested that policies requiring parental consent prior to HPV vaccine administration to minors may be a barrier to direct communication with adolescents. 107,108 In terms of barriers related to the clinical environment, studies most often identified deficiencies in scheduling as limiting provider communication about HPV vaccination. Providers identified patient reminder/recall as critical to their efforts to recommend HPV vaccination, but many reported that they did not use these systems, and instead relied on patients to initiate scheduling.…”

Section: Visit Typementioning

confidence: 99%

Provider communication about HPV vaccination: A systematic review

Gilkey

McRee

2016

Human Vaccines & Immunotherapeutics

Self Cite

258

220

View full text Add to dashboard Cite

Background. Improving HPV vaccination coverage in the US will require healthcare providers to recommend the vaccine more effectively. To inform quality improvement efforts, we systematically reviewed studies of provider communication about HPV vaccination. Methods. We searched MEDLINE, CINAHL, EMBASE, and POPLINE in August 2015 to identify studies of provider communication about HPV vaccination. Results. We identified 101 qualitative and quantitative studies. Providers less often recommended HPV vaccine if they were uncomfortable discussing sex, perceived parents as hesitant, or believed patients to be low risk. Patients less often received recommendations if they were younger, male, or from racial/ethnic minorities. Despite parents' preference for unambiguous recommendations, providers often sent mixed messages by failing to endorse HPV vaccine strongly, differentiating it from other vaccines, and presenting it as an "optional" vaccine that could be delayed. Conclusion. Interventions are needed to help providers deliver effective recommendations in the complex communication environment surrounding HPV vaccination.

show abstract

Section: Visit Typementioning

confidence: 99%

Provider communication about HPV vaccination: A systematic review

Gilkey

McRee

2016

Human Vaccines & Immunotherapeutics

Self Cite

258

220

View full text Add to dashboard Cite

show abstract

“…[21][22][23][24] The infrequency of adolescent visits to primary care clinics during the ages of 13 to 17 years makes it all the more important to bundle immunizations as a package to ensure initiation and multidose completion.…”

mentioning

confidence: 99%

“…Students in these settings are easier to access, and the school year is long enough to complete vaccination in a multidose series. 24,25 Limitations Given that this research reflects the views and experiences of clinicians and immunization experts who work with underserved ethnic minority and rural populations, it is possible that these findings are relevant to these circumstances and not to conditions of vaccine delivery across the country. Our findings, however, are widely consistent with those reported in the broader literature while offering perspectives that may be uniquely relevant to primary care clinicians and researchers working in similar contexts.…”

mentioning

confidence: 99%

Catching Up With the HPV Vaccine: Challenges and Opportunities in Primary Care

Sussman

Helitzer

Bennett

et al. 2015

The Annals of Family Medicine

View full text Add to dashboard Cite

PURPOSE Data confirm that high rates of human papillomavirus (HPV) vaccination have not been achieved despite strong clinician endorsement of the vaccine. We conducted a study of primary care clinicians to assess the broad range of health care delivery, health policy, and attitudinal factors influencing vaccination uptake and opportunities for informed decision making. METHODSWe implemented a mixed methods study in RIOS Net, a primary care practice-based research network in New Mexico. We first conducted qualitative, in-depth interviews with primary care clinicians, health policy makers, and immunization experts, and followed up with a confirmatory survey distributed to RIOS Net clinician members. RESULTSHealth service delivery challenges emerged as the greatest barrier to HPV vaccination, specifically the lack of capacity to track and distribute reminders to eligible patients. Clinicians also reported variations in counseling approaches attributable to both age and emphasis on the cancer prevention benefits of the vaccine. There was no evidence of sociocultural influences on vaccine decision making, nor did concerns about perceived overprotection emerge.CONCLUSIONS Our findings, based on a long-term program of research, suggest that both patients' attributes and health system delivery are most influential in HPV vaccination coverage challenges. Interventions targeting innovative communication techniques, as well as health system changes that build on efforts toward coordinated care and utilization of other venues to promote vaccination, will be necessary to address these challenges. Control and Prevention (CDC) reports that the human papillomavirus (HPV) vaccine rates trail those of other vaccines for teenagers: tetanus, diphtheria, and pertussis (Tdap), and menningitis. INTRODUCTION T he Centers for Disease1 Nationally, 57.3% reported getting the first dose of HPV in 2013, a modest increase from 2012 rates (53.8%). Full coverage (not considering the time frame in which the doses were given) is also less than ideal: among girls aged 13 to 17 years, 37.6% received all 3 doses. National HPV vaccination data for younger eligible recipients (eg, aged 9 to 12 years) are not provided by the CDC. Given new challenges in the health service delivery environment, 3 innovative approaches for increasing HPV vaccination coverage are needed.In the period before the vaccine's release, research was aimed at understanding factors that might predict vaccination uptake. Although identification of such factors varied, there was strong consensus that primary care clinicians would play an important role in HPV vaccine dissemination. [4][5][6] During the prelicensure period, we conducted a qualitative study in primary care settings to better understand and anticipate the challenges and opportunities for HPV vaccination. In this journal, we reported the 4 major domains that emerged from our research, which included (1) the complexity of HPV counseling in the clinical encounter, (2) the recom- 355mended age, (3) system/compl...

show abstract

“…7,8 Previous studies have also indicated that parents report greater willingness to consent to having their child receive HPV vaccine in the context of an SLVP that includes multiple adolescent vaccines versus an SLVP that provides HPV vaccine only. 9,10 An SLVP conducted among middle schools in Denver also experienced good uptake of HPV vaccine among those participating in the program; other than the flu vaccine, HPV vaccines were administered most frequently to participants (the denominator of the proportion was all vaccines administered, not unique recipients). 11 The data presented here imply that if participants are already willing to have their child receive vaccines using an SLVP, they will also likely consent for the HPV vaccine through the SLVP.…”

Section: Discussionmentioning

confidence: 99%